M3.com
VC Fund
Tokyo, Japan
M3.com is a Tokyo-based company, providing medical-related services through the use of the internet. The company was founded with the goal of changing the world of medicine through full use of the power of the internet.M3.com represents the three Ms of medicine, media, and metamorphosis. The company provides its users with the latest medicalinformation and also serves as a source of information for health care workers. It is currently being used by more than 200,000 physicians, including more than 100,000 pharmacists, and trusted by more than 700,000 health care professionals.M3.com was established in 2000 with Sony Communications Network Corporation, a supplier of network-related services, as the largest stockholder. The company was founded in 2003.
- Total investments:
- 6
- Last investment:
- Lead investor:
- 17%
Last updated:
For AI agents: llms.txt
Industries M3.com invests in
Stages M3.com invests in
Countries M3.com invests in
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
3 more contacts available
Investment Focus
Industry
- Medical 3 (50%)
- Health Care 3 (50%)
- Biotechnology 2 (33%)
- Toys 1 (17%)
- Books 1 (17%)
Stage
- Seed 1 (17%)
- Series A 1 (17%)
- Series B 1 (17%)
- Series C 1 (17%)
- Corporate Round 1 (17%)
Country
- Japan 4 (67%)
- Spain 1 (17%)
- United States 1 (17%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
|
Itaru Tanimura
Founder
|
Founder | Total investments: 0 | Find email | |
|
Paul J. Rice
Chief Operating Officer
|
Chief Operating Officer | Total investments: 0 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Compass
|
Compass offering services in the tourism and inbound sector, including accommodation support, optional tour planning and management, kimono rentals, and tourism consulting services | $4.8M / Series B / Mar 06, 2026 | |
iDoctus
|
iDoctus develops mobile and online clinical information and decision support software that enables Latinamerican and Spain's physicians to find answers more quickly and confidently at the point of care. Currently almost 20% of physicians in target regions use our smartphone and tablet applications. | Corporate Round / Jun 08, 2022 | |
Kringle Pharma
|
Kringle Pharma, Inc., a biopharmaceutical company, develops pharmaceutical products based on its research on hepatocyte growth factor (HGF) and NK4. Its HGF has the regenerative healing ability in regard to liver cells, as well as various cells and organs; and NK4 is a bi-functional molecule, which inhibits the invasion and metastasis of tumorcells as an HGF-antagonist, as well as possesses antiangiogenic activity. The company’s pipeline includes recombinant human HGF for the treatment of acute renal failure, skin ulcers, and CNS diseases; and recombinant human NK4 and NK4 gene drugs for cancer therapy. Kringle Pharma, Inc. was founded in 2001 and is based in Toyonaka, Japan. | $8.8M / Venture - Series Unknown / Feb 28, 2020 | |
UniFa
|
UniFa is the developer of LookMee, an AI and IoT-powered healthcare solution for tracking kindergarteners' physical and mental growth. The system consists of LookMee Nap Check, an IoT sensor that aims to secure a baby's naptime; LookMee thermometer, which measures and monitors the baby's body temperature; and LookMee Photo, acommunication and photo-sharing service that collects data from children at kindergarten to give parents a better idea of their child's well-being | $32M / Series C / Sep 27, 2019 | |
BackTech
|
BackTech offers information on health management and collaboration health, and health issues for working people.The company operates and provides comprehensive support from visualization of organizational productivity to solutions. Backtech's "Pocket Therapist" application for shoulder stiffness and low back pain measures aimed atreducing medical expenses and improving productivity in order to solve the problems of "working performance decline" and "stiff neck and low back pain difficult to solve with existing solutions". | $28.3M / Series A / Mar 20, 2019 | |
Genomelink
|
Genomelink is a platform where people discover more with their DNA data and help businesses build, market and do research with it. The best founders in consumer genomics with real experience in the industry for many years, including M3, Inc. ($13B valued Meditech in Japan), a founding member of the Japanese version of 23andMe, and leadbioinformatician and software engineer at a joint-venture between Illumina and Sony. Raised $4M for Seed Round from Berkeley SkyDeck, SONY, and top-tier Japanese VCs. Supported by Illumina Accelerator, Carlos Bustamante Lab at Stanford University among others. | $7.1M / Seed / Aug 22, 2017 |
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Featured in Investor Lists
Recommended lists
FAQ
What does M3.com invest in?
M3.com invests primarily in Medical, Health Care and Biotechnology startups, most often at Seed and Series A stage. Most of the 6 investments tracked by Shizune back companies in Japan. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact M3.com?
Public channels for M3.com include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at M3.com?
The team at M3.com includes Itaru Tanimura (Founder) and Paul J. Rice (Chief Operating Officer). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
